Evaluate Vantage: Aduhelm approval amplifies amyloid assays

Written By Joni Henderson

Biogen needs blood tests for amyloid beta to progress quickly – and several are in the pipeline.

Joni Henderson
Previous

Science Magazine: Blood tests could help screen anticipated flood of patients seeking new Alzheimer’s drug
Next

360Dx: C₂N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space